Proliferative cells have more negative steaty-state redox potential and differentiated cells have more positive cells and cells undergoing apoptosis and necrosis have a more oxidized steady-state potential (around -170 mmol/L to -150 mmol/L)[45]
The future of metabolic medicine appears to be moving toward more complex, multi-pathway interventions that address the full spectrum of metabolic dysfunction
Interestingly, most of these abnormalities could be partially or completely corrected by the administration of CoQ10 in animal models
Prescribers screen for contraindications (e.g., certain endocrine tumor syndromes) and review your medical history for past issues, such as pancreatitis, when evaluating whether GLP-1 medication is appropriate
GIP/GLP-1/glucagon (GCG) triple agonists represent a particularly exciting new drug class that is being studied in patients with obesity
Results persist but gradually return toward baseline without ongoing support